Table 4.
Adherence for content, dose, and duration by facility level and overall (n = 254 FCM administrations)
| Content | Primary (five facilities) (n = 75) (%) | Secondary (four facilities) (n = 160) (%) | Tertiary (two facilities) (n = 19) (%) |
All facilities (n = 254) (%) |
|---|---|---|---|---|
| 1. Ensure the availability of the following resuscitation medications and materials at the point of administration | ||||
| i. Adrenaline | 61 (81.3) | 144 (90.0) | 17(89.4) | 222(87.4) |
| ii. IV Chlorpheniramine | 57 (76.0) | 144 (90.0) | 16 (84.2) | 217 (85.4) |
| iii. IV Ranitidine | 61 (81.3) | 144 (90.0) | 17 (89.5) | 222 (87.4) |
| iv. Oral Ranitidine | 55 (73.3) | 141 (88.1) | 16 (84.2) | 212 (83.5) |
| v. IV hydrocortisone | 61 (81.3) | 154 (96.2) | 17 (89.5) | 232 (91.3) |
| vi. 500mls/1L bottle normal saline | 61 (81.3) | 156 (97.5) | 17 (89.5) | 234 (92.1) |
| vii. Intravenous fluid giving set | 63 (84.0) | 160(100.0) | 18 (94.7) | 241 (94.9) |
| viii. Oxygen mask | 40 (53.3) | 131 (81.9) | 16 (84.2) | 187 (73.6) |
| ix. Oxygen cylinder | 38 (50.7) | 158 (98.8) | 17 (89.5) | 213 (83.9) |
| Total median score for component 1 (IQR) | 88.9 (66.7–100.0) | 100.0 (100.0,100.0) | 100.0 (100.0,100.0) | 100.0 (88.9–100.0) |
| 2. Ensure availability of FCM | 75 (100.0) | 160(100.0) | 19(100.0) | 254 (100.0) |
| 3. Patient counselling | 62 (82.7) | 160(100.0) | 19(100.0) | 241 (94.9) |
| 4. Confirm patient’s randomization group is FCM | 75 (100.0) | 160(100.0) | 19(100.0) | 254 (100.0) |
| 5. Obtain verbal consent for FCM administration from participants | 65 (86.7) | 159 (99.4) | 19 (100.0) | 243 (95.6) |
| 6. Perform baseline vital signs | 65 (86.7) | 159 (99.4) | 19 (100.0) | 243 (95.6) |
| 7. Calculation of individual dose at 20 mg/Kg body weight up to a maximum dose of 1000 mg | 75 (100.0) | 156 (97.5) | 19 (100.0) | 250 (98.4) |
| 8. Set up the administration at a low flow rate | 70 (93.3) | 158 (98.8) | 19 (100.0) | 247 (97.3) |
| 9. Observe the patient closely and monitor vital signs for the first 2 min | 59 (78.7) | 159 (99.4) | 19 (100.0) | 237(93.3) |
| 10. Post-administration vital signs check | 54 (72.0) | 160(100.0) | 19 (100.0) | 233 (91.7) |
| Total median score for content (IQR) | 97.8 (81.1–100.0) | 100 (100.0, 100.0) | 100 (100.0, 100.0) | 100.0 (97.8–100.0) |
| Dose | ||||
| Withdraw the equivalent volume of the calculated dose | 75 (100.0) | 159(99.4) | 19 (100.0) | 253 (99.6) |
| Duration | ||||
| Patient is observed for adverse effects for at least 30 min following administration | 69 (92.0) | 155 (96.9) | 18 (94.7) | 242 (95.3) |
IQR Interquartile range